चिकित्सा कैंसर विज्ञान

2. आधारभूत संरचना

• 20-बिस्तरों वाला चिकित्सा ऑन्कोलॉजी वार्ड

• 20-बिस्तरों वाला डे-केयर कीमोथेरेपी केंद्र

• अस्थि मज्जा प्रत्यारोपण (Bone Marrow Transplant – BMT) इकाई

• नैदानिक अनुसंधान (Clinical Research) इकाई

• सम्मेलन एवं शैक्षणिक सभागार

• समर्पित चिकित्सा ऑन्कोलॉजी बाह्य रोगी विभाग (ओपीडी)

• आधुनिक कीमोथेरेपी औषधि तैयारी एवं प्रशासन सुविधाएँ

• बहुविषयक ट्यूमर बोर्ड (Multidisciplinary Tumour Board) की सुविधाएँ

3. उपलब्ध सेवाएँ

• कीमोथेरेपी

• इम्यूनोथेरेपी

• लक्षित चिकित्सा (Targeted Therapy)

• हार्मोनल चिकित्सा

• सहायक एवं उपशामक (Palliative) देखभाल

• डे-केयर कीमोथेरेपी

• अस्थि मज्जा प्रत्यारोपण (Bone Marrow Transplantation)

• सीएआर-टी सेल थेरेपी (CAR-T Cell Therapy) — संस्थागत प्रोटोकॉल के अनुसार

• क्लिनिकल ट्रायल तथा बहुविषयक ट्यूमर बोर्ड परामर्श

5. बाह्य रोगी विभाग (OPD) एवं विशेषज्ञ क्लिनिक

स्थान: भूतल, मेडिकल ऑन्कोलॉजी ब्लॉक।

मेडिकल ऑन्कोलॉजी ओपीडी सभी कार्य दिवसों में नए तथा फॉलो-अप रोगियों के लिए संचालित होती है। रोग-विशिष्ट क्लिनिक तथा बहु-विषयक ट्यूमर बोर्ड (Multidisciplinary Tumour Board) की बैठकें नियमित रूप से आयोजित की जाती हैं।

6. अनुसंधान एवं प्रकाशन

विभाग राष्ट्रीय एवं अंतरराष्ट्रीय क्लिनिकल ट्रायल, अन्वेषक-प्रेरित (Investigator-Initiated) अनुसंधान, शैक्षणिक प्रकाशनों तथा सहयोगात्मक ऑन्कोलॉजी अनुसंधान में सक्रिय रूप से भाग लेता है।

• Vineet Talwar 1, Kaushal Kalra 2, Akhil Kapoor 3, P S Dattatreya 4, Amit Joshi 5, Krishna Chaitanya 6, M V Chandrakanth 7, Atul Batra 8, Krishna Prasad 9, Nikhil Haridas 10, Nilesh Lokeshwar 11. Evolving Treatment Paradigms in Metastatic Hormone-Sensitive Prostate Cancer: Expert Narrative Review, Affiliations Expand. PMID: 40862806 PMCID: PMC12384610 DOI: 10.3390/curroncol32080437. 

• Adhip Arora 1, V Seenu 2, Rajinder Parshad 2, V K Bansal 2, Anita Dhar 2, Sandeep Mathur 3, Pranay Tanwar 4, Piyush Mishra 2, Kamal Kataria 2, Suhani 2, Ajay Gogia 1, Brijesh Kumar 2, K P Haresh 5, Supriya Mallick 5, Surendra Kumar Saini 5, Ashutosh Mishra 6, Babul Bansal 6, Jyoti Sharma 6, Jyoutishman Saikia 6, Krithika Rangarajan 7, Ekta Dhamija 7, Chandra Prakash Prasad 4, Shamim Ahmed Shamin 8, Sourabh Agastm 9, Kaushal Kalra 10, Divvay Vishvam 10, Kalaivani Mani 11, Akash Kumar 1, Sameer Bakhshi 1, Atul Batra 12. A phase II, randomized, open-labeled study to evaluate low-dose pembrolizumab in addition to neoadjuvant chemotherapy for triple-negative breast cancer (TNBC), Affiliations Expand

• Arora, A. & Seenu, V. & Parshad, Rajinder & Kalra, K. & Kumar, A. & Bakhshi, Sameer & Batra, Atul. (2025). 266TiP A phase II, randomized, open- labelled study to evaluate low-dose pembrolizumab in addition to neoadjuvant chemotherapy for triple-negative breast cancer (TNBC). ESMO Open. 10. 104820. 10.1016/j.esmoop.2025.104820.

• Arora, Adhip & Seenu, V. & Parshad, Kalra, K & Batra, Atul. (2025). A phase II, randomized, open-labeled study to evaluate low-dose pembrolizumab in addition to neoadjuvant chemotherapy for triple-negative breast cancer (TNBC). Trials. 26. 73. 10.1186/s13063-025-08726-9.

• Kothari, Rushabh & Doshi, Maulik & Chaithanya, & Kalra, Kaushal & Nemade, Bhushan & Parmar, Deven. (2024). A Randomized, Double-Blind, Phase III Study in India for Comparing Efficacy, Safety, and PK of ZRC-3277 (Pertuzumab Biosimilar) With Perjeta® in Patients With HER2-Positive Metastatic Breast Cancer. Clinical Breast Cancer. 24. 10.1016/j.clbc.2024.07.001.

• Challenges in Diagnosis: Ovarian Dysgerminoma Presenting as Torsion in a Prepubertal Girl: A Case Report Sumedha Gupta, Varsha Motwani Dheer. Kaushal  Kalra 

• Navigating Gestational Trophoblastic Neoplasia: Lessons From 15 Cases at a North Indian Tertiary Care Center. Saloni Chadha. Sumedha Gupta, Dheer Singh, Kaushal Kalra 

• Borderline tumors (1) Meetu Agrawal Divya Sethi Neha Kawatra Madan Sana Ahuja Saritha Shamsunder Kaushal Kalra 

• Unusual lymphoma at unusual sites Meetu Agrawal Ajay Joseph Kaushal Kalra Neha Kawatra Madan

• Arora S, Pushpam D, Tiwari A, et al. Allogeneic hematopoietic stem cell transplant in pediatric acute myeloid leukemia: lessons learnt from a tertiary care center in India. Pediatric Transplant. 2021;25:e13918.

• Verma, Saurav & Kalra, Kaushal & Rastogi, Sameer & Dhamija, Ekta & Upadhyay, Avinash & Mittal, Abhenil & Aggarwal, Aditi & Shamim, Shamim. (2021). Trabectedin in Advanced Sarcomas—Experience at a Tertiary Care Center and Review of Literature. South Asian Journal of Cancer. 10. 53-57. 10.1055/s-0041-1734336.

• Verma, Saurav & Kalra, Kaushal & Rastogi, Sameer & Sidhu, Harsumeet. (2020). Clinical approach to childhood mediastinal tumors and management. Mediastinum. 4. 21-21. 10.21037/med-19-82.

• Shishak, Sorun & Rastogi, Sameer & Kalra, Kaushal & Parisa, Manasa. (2020). STRASS trial: Preoperative radiotherapy in retroperitoneal sarcoma: A commentary. Journal of Cancer Research and Therapeutics. 17. 10.4103/jcrt.JCRT_573_19.

• Rastogi, Sameer & Kalra, Kaushal & Manasa, Parisa & Rajawat, Monali & Mehta, Varshil. (2019). Long lasting response of trabectedin in patient with gastric leiomyosarcoma with liver metastasis: an update to previous report. FSO432. 10.2144/fsoa-2019-0085.

• Pawar, S & Rastogi, Sameer & Dhamija, Ekta & Barwad, A & Kumar, V & Pandey, Rambha & Shishak, S & Kalra, K & Aggarwal, Aditi & Garg, A & Mridha, A & Chaubey, J & Khan, S. (2019). 418PLessons learnt from treatment of foot sarcomas: Analysis from dedicated sarcoma clinic in North India. Annals of Oncology. 30. 10.1093/annonc/mdz433.015.

• Shishank, S & Rastogi, Sameer & Pandey, Rambha & Barwad , A & Dhamija , Ekta & Agarwal , Aditi & Kalra K & Shamim, Shamim & Parisa, M .(2019). 348P Malignant melonoma: A study of clinical profiles and treatment outcomes in Indian patients. Annals of Oncology.30.10.1093/annoc/mdz429.007.

• Rastogi, Sameer & Manasa, Parisa & Agarwal, Aditi & Kalra, Kaushal. (2019). Advance in soft-tissue sarcoma- There are no mistakes, only lessons to learn ! South Asian Journal of Cancer. 8.258.10.4103/sajc.sajc_215_19

7. कार्यक्रम (Events)

वर्षभर नियमित रूप से सीएमई (CME), कार्यशालाएं, संगोष्ठियां, ट्यूमर बोर्ड बैठकें एवं कैंसर जागरूकता कार्यक्रम आयोजित किए जाते हैं।

8. पाठ्यक्रम (Courses)

एमबीबीएस छात्रों, स्नातकोत्तर रेजिडेंट्स, वरिष्ठ रेजिडेंट्स, ऑन्कोलॉजी प्रशिक्षुओं, नर्सिंग स्टाफ तथा पर्यवेक्षकों/फेलो के लिए प्रशिक्षण प्रदान किया जाता है।

9. शिक्षण एवं प्रशिक्षण (Teaching & Training)

दैनिक शैक्षणिक गतिविधियों में सेमिनार, जर्नल क्लब, केस प्रस्तुतियां, मृत्यु समीक्षा बैठकें तथा कीमोथेरेपी, बोन मैरो ट्रांसप्लांटेशन और उन्नत ऑन्कोलॉजी प्रथाओं में व्यावहारिक प्रशिक्षण शामिल हैं।

10. उपलब्धियां एवं पुरस्कार (Achievements & Awards)

विभाग ने उन्नत कैंसर उपचार सुविधाएं स्थापित की हैं, जिनमें समर्पित मेडिकल ऑन्कोलॉजी ब्लॉक, डे-केयर कीमोथेरेपी सेंटर, बोन मैरो ट्रांसप्लांट कार्यक्रम तथा अंतरराष्ट्रीय बहुकेंद्रीय क्लिनिकल परीक्षणों में भागीदारी शामिल है।